Immune Cells Involved in the Pathogenesis of Ankylosing Spondylitis

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Immune Cells Involved in the Pathogenesis of Ankylosing Spondylitis Publisher Pubmed

Rezaiemanesh A¹ ; Abdolmaleki M² ; Abdolmohammadi K² ; Aghaei H² ; Pakdel FD² ; Fatahi Y³ ; Soleimanifar N⁴ ; Zavvar M² ; Nicknam MH^{2, 4}

Source: Biomedicine and Pharmacotherapy Published:2018

Abstract

Ankylosing spondylitis (AS) is an inflammatory autoimmune disease. AS is a prototype form of spondyloarthropathies (SpA). The precise etiology of AS has not been fully understood. But Inflammation has a critical role in the pathogenesis of the disease. The immune system by various cells, secreted-mediators and markers manage and regulate the immune responses and inflammation. Every factor which disturbed this regulation and hemostasis can cause chronic inflammation. In this review, we discussed the role of several innate and adaptive immune cells involved in the triggering, initiation, development, and regulation of AS. © 2018

Related Docs

View other Related Docs

1. Innate Immune-Related Cells and Cytokines in Spondyloarthropathies, Ankylosing Spondylitis - Axial Spondyloarthritis: Cellular# Molecular and Environmental Factors (2021)

2. Adaptive Immune-Related Cells and Cytokines in Spondyloarthropathies, Ankylosing Spondylitis - Axial Spondyloarthritis: Cellular# Molecular and Environmental Factors (2021)

3. Assessment of Immunological Profile in Ankylosing Spondylitis Patients Following a Clinical Trial With Guluronic Acid (G2013), As a New Nsaid With Immunomodulatory Properties, Immunologic Research (2019)

Experts (# of related papers)

View all Related Experts

Mahdi Mahmoudi (12)

Ahmad Reza Jamshidi (10)

Other Related Docs

4. Role of Innate Immune System in the Pathogenesis of Ankylosing Spondylitis, Biomedicine and Pharmacotherapy (2018)

5. An Overview to Ankylosing Spondylitis and Spondyloarthropathies, Ankylosing Spondylitis - Axial Spondyloarthritis: Cellular# Molecular and Environmental Factors (2021)

6. Ankylosing Spondylitis and Mesenchymal Stromal/Stem Cell Therapy: A New Therapeutic Approach, Biomedicine and Pharmacotherapy (2019)

7. Nk Cells - Dr. Jekyll and Mr. Hyde in Autoimmune Rheumatic Diseases, International Immunopharmacology (2022)

8. Association Study Between Killer Immunoglobulin-Like Receptor Polymorphisms and Ankylosing Spondylitis Disease: An Updated Meta-Analysis, International Journal of Rheumatic Diseases (2018)

9. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their Hla Ligands in Iranian Patients With Ankylosing Spondylitis, Iranian Journal of Allergy# Asthma and Immunology (2016)

10. Ankylosing Spondylitis M-Csf-Derived Macrophages Are Undergoing Unfolded Protein Response (Upr) and Express Higher Levels of Interleukin-23, Modern Rheumatology (2017)

11. Copy Number Variation of Il17ra Gene and Its Association With the Ankylosing Spondylitis Risk in Iranian Patients: A Case-Control Study, BMC Medical Genetics (2020)

12. Oral Administration Effects of Β-D-Mannuronic Acid (M2000) on Th17 and Regulatory T Cells in Patients With Ankylosing Spondylitis, Biomedicine and Pharmacotherapy (2018)

13. Th22 Cells Contribution in Immunopathogenesis of Rheumatic Diseases, Iranian Journal of Allergy# Asthma and Immunology (2015)

14. Determination of Il1 R2, Antxr2, Card9, and Snapc4 Single Nucleotide Polymorphisms in Iranian Patients With Ankylosing Spondylitis, Rheumatology International (2016)

15. New Insights Toward the Pathogenesis of Ankylosing Spondylitis; Genetic Variations and Epigenetic Modifications, Modern Rheumatology (2017)

16. Activation of Adenosine A2a Receptor Induced Interleukin-23 Mrna Expression in Macrophages of Ankylosing Spondylitis Patients, Cytokine (2020)

17. Potential Roles for B Cells and Autoantibodies in Ankylosing Spondylitis, Current Rheumatology Reviews (2024)

18. Hla-B*27 Subtypes and Their Implications in the Pathogenesis of Ankylosing Spondylitis, Gene (2018)

19. Promoter Hypermethylation of Bcl11b Gene Correlates With Downregulation of Gene Transcription in Ankylosing Spondylitis Patients, Genes and Immunity (2017)

20. The Potent Suppressive Effect of Β-D-Mannuronic Acid (M2000) on Molecular Expression of the Tlr/Nf-Kb Signaling Pathway in Ankylosing Spondylitis Patients, International Immunopharmacology (2017)

Style	Citing Format
MLA	Rezaiemanesh A, et al.. "Immune Cells Involved in the Pathogenesis of Ankylosing Spondylitis." Biomedicine and Pharmacotherapy, vol. 100, no. , 2018, pp. 198-204.
APA	Rezaiemanesh A, Abdolmaleki M, Abdolmohammadi K, Aghaei H, Pakdel FD, Fatahi Y, Soleimanifar N, Zavvar M, Nicknam MH (2018). Immune Cells Involved in the Pathogenesis of Ankylosing Spondylitis. Biomedicine and Pharmacotherapy, 100(), 198-204.
Chicago	Rezaiemanesh A, Abdolmaleki M, Abdolmohammadi K, Aghaei H, Pakdel FD, Fatahi Y, Soleimanifar N, Zavvar M, Nicknam MH. "Immune Cells Involved in the Pathogenesis of Ankylosing Spondylitis." Biomedicine and Pharmacotherapy 100, no. (2018): 198-204.
Harvard	Rezaiemanesh A et al. (2018) 'Immune Cells Involved in the Pathogenesis of Ankylosing Spondylitis', Biomedicine and Pharmacotherapy, 100(), pp. 198-204.
Vancouver	Rezaiemanesh A, Abdolmaleki M, Abdolmohammadi K, Aghaei H, Pakdel FD, Fatahi Y, et al.. Immune Cells Involved in the Pathogenesis of Ankylosing Spondylitis. Biomedicine and Pharmacotherapy. 2018;100():198-204.
BibTex	@article{ author = {Rezaiemanesh A and Abdolmaleki M and Abdolmohammadi K and Aghaei H and Pakdel FD and Fatahi Y and Soleimanifar N and Zavvar M and Nicknam MH}, title = {Immune Cells Involved in the Pathogenesis of Ankylosing Spondylitis}, journal = {Biomedicine and Pharmacotherapy}, volume = {100}, number = {}, pages = {198-204}, year = {2018} }
RIS	TY - JOUR AU - Rezaiemanesh A AU - Abdolmaleki M AU - Abdolmohammadi K AU - Aghaei H AU - Pakdel FD AU - Fatahi Y AU - Soleimanifar N AU - Zavvar M AU - Nicknam MH TI - Immune Cells Involved in the Pathogenesis of Ankylosing Spondylitis JO - Biomedicine and Pharmacotherapy VL - 100 IS - SP - 198 EP - 204 PY - 2018 ER -

Science Communicator Platform

Authors

Abstract